Previous publication The results of this study were presented in part as oral presentation (late breaking news in clinical allergology) at the XXVI Congress of the European Academy of Allergology and Clinical Immunology in Göteborg, Sweden, 9–13 June 2007.
Safety of ultra-rush titration of sublingual immunotherapy in asthmatic children with tree-pollen allergy
Article first published online: 15 NOV 2010
© 2010 John Wiley & Sons A/S
Pediatric Allergy and Immunology
Volume 21, Issue 8, pages 1135–1138, December 2010
How to Cite
Mösges, R., Graute, V., Christ, H., Sieber, H.-J., Wahn, U. and Niggemann, B. (2010), Safety of ultra-rush titration of sublingual immunotherapy in asthmatic children with tree-pollen allergy. Pediatric Allergy and Immunology, 21: 1135–1138. doi: 10.1111/j.1399-3038.2010.01078.x
- Issue published online: 15 NOV 2010
- Article first published online: 15 NOV 2010
- Accepted 13 January 2010
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.